| Pathophysiology and treatment of systemic amyloidosis JD Gillmore, PN Hawkins Nature Reviews Nephrology 9 (10), 574-586, 2013 | 150 | 2013 |
| Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 93 | 2023 |
| 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients F Gejyo, A Saito, T Akizawa, T Akiba, T Sakai, M Suzuki, S Nishi, ... Therapeutic Apheresis and Dialysis 8 (6), 443-459, 2004 | 78 | 2004 |
| Impact of hemodialysis dose and frequency on survival of patients on chronic hemodialysis in Lithuania during 1998–2005 A Stankuvienė, E Žiginskienė, V Kuzminskis, IA Bumblytė Medicina 46 (8), 516, 2010 | 60 | 2010 |
| Hemodiyaliz hastalarının Pittsburgh uyku kalite indeksi ile değerlendirilmesi M Çölbay, Ş Yüksel, F Fidan, G Acartürk, Ö Karaman, M Ünlü Tüberküloz ve Toraks Dergisi 55 (2), 167-173, 2007 | 59 | 2007 |
| Sleep disorders and quality of life in patients on hemodialysis N Kusleikaite, IA Bumblyte, L Razukeviciene, D Sedlickaite, K Rinkūnas Medicina (Kaunas, Lithuania) 41, 69-74, 2005 | 49 | 2005 |
| Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial BH Rovin, J Barratt, HJL Heerspink, CE Alpers, S Bieler, DW Chae, ... The Lancet 402 (10417), 2077-2090, 2023 | 45 | 2023 |
| Chronic kidney disease and neurological disorders: are uraemic toxins the missing piece of the puzzle? S Liabeuf, M Pepin, CFM Franssen, D Viggiano, S Carriazo, ... Nephrology Dialysis Transplantation 37 (Supplement_2), ii33-ii44, 2022 | 44 | 2022 |
| The association between health-related quality of life and mortality among hemodialysis patients N Kušleikaitė, IA Bumblytė, V Kuzminskis, R Vaičiūnienė Medicina 46 (8), 531, 2010 | 43 | 2010 |
| Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment M Pépin, AC Ferreira, M Arici, M Bachman, M Barbieri, IA Bumblyte, ... Nephrology Dialysis Transplantation 37 (Supplement_2), ii23-ii32, 2022 | 39 | 2022 |
| Factors influencing renal graft survival: 7-Year experience of a single center R Auglienė, E Dalinkevičienė, V Kuzminskis, M Jievaltas, L Peleckaitė, ... Medicina 53 (4), 224-232, 2017 | 33 | 2017 |
| Adherence to treatment and hospitalization risk in hemodialysis patients. R Vaiciuniene, V Kuzminskis, E Ziginskiene, I Skarupskiene, IA Bumblyte Journal of nephrology 25 (5), 672-678, 2012 | 33 | 2012 |
| Nationwide renal biopsy data in Lithuania 1994–2012 E Brazdziute, M Miglinas, E Gruodyte, J Priluckiene, A Tamosaitis, ... International urology and nephrology 47, 655-662, 2015 | 29 | 2015 |
| Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients K Petrulienė, E Žiginskienė, V Kuzminskis, I Nedzelskienė, IA Bumblytė Medicina 53 (2), 90-100, 2017 | 27 | 2017 |
| Acidosis, cognitive dysfunction and motor impairments in patients with kidney disease PH Imenez Silva, R Unwin, EJ Hoorn, A Ortiz, F Trepiccione, R Nielsen, ... Nephrology Dialysis Transplantation 37 (Supplement_2), ii4-ii12, 2022 | 26 | 2022 |
| Albuminuria as a risk factor for mild cognitive impairment and dementia—what is the evidence? B Bikbov, MJ Soler, V Pešić, G Capasso, R Unwin, M Endres, G Remuzzi, ... Nephrology Dialysis Transplantation 37 (Supplement_2), ii55-ii62, 2022 | 23 | 2022 |
| Mortality prediction in patients with acute kidney injury requiring renal replacement therapy after cardiac surgery I Skarupskienė, D Adukauskienė, J Kuzminskienė, L Rimkutė, ... Medicina 53 (4), 217-223, 2017 | 19 | 2017 |
| The prevalence of Fabry's disease among male patients on hemodialysis in Lithuania (a screening study) R Maslauskiene, IA Bumblyte, E Sileikiene, S Grazulis, A Laurinavicius, ... Medicina (Kaunas, Lithuania) 43, 77-80, 2007 | 19 | 2007 |
| Immune response after SARS-CoV-2 vaccination in kidney transplant patients R Vaiciuniene, B Sitkauskiene, IA Bumblyte, E Dalinkeviciene, ... Medicina 57 (12), 1327, 2021 | 18 | 2021 |
| The level of endotoxins in hemodialysis water and dialysate in Lithuanian hemodialysis centers I Skarupskienė, IA Bumblytė, D Tamošaitis, J Venterienė, V Kuzminskis Medicina 46 (8), 556, 2010 | 16 | 2010 |
